Cellev8 Nutrition Inc (Formerly Preferred Commerce) Clarifies Business Focus and Highlights Benefits of Superoxide Dismutase Supplements
Cellev8 Nutrition Inc (OTC PINK:CELV) has issued a statement retracting previous announcements about entering the CBD/Cannabis industry, clarifying that no agreements were finalized in this sector. The company has instead positioned itself as a pioneer in Superoxide Dismutase (SOD) based supplements, becoming the first to deliver SOD in gummy form commercially. The company serves thousands of customers, including over 40 professional and collegiate athletic teams, focusing on products for inflammation, recovery, focus, and memory support.
Cellev8 Nutrition Inc (OTC PINK:CELV) ha emesso una dichiarazione che ritira precedenti annunci riguardanti l'ingresso nel settore CBD/Cannabis, precisando che non sono stati finalizzati accordi in questo ambito. L'azienda si è invece posizionata come pioniere nei supplementi a base di Superossido Dismutasi (SOD), diventando la prima a offrire SOD in forma di gomma a livello commerciale. L'azienda serve migliaia di clienti, tra cui oltre 40 squadre sportive professionistiche e universitarie, concentrandosi su prodotti per l'infiammazione, il recupero, la concentrazione e il supporto della memoria.
Cellev8 Nutrition Inc (OTC PINK:CELV) ha emitido un comunicado retractándose de anuncios anteriores sobre su entrada en la industria del CBD/Cannabis, aclarando que no se han finalizado acuerdos en este sector. En su lugar, la empresa se ha posicionado como pionera en suplementos a base de Dismutasa Superóxido (SOD), siendo la primera en comercializar SOD en forma de gomita. La compañía atiende a miles de clientes, incluidos más de 40 equipos atléticos profesionales y universitarios, enfocándose en productos para la inflamación, la recuperación, la concentración y el apoyo de la memoria.
Cellev8 Nutrition Inc (OTC PINK:CELV)는 CBD/대마 산업에 진입하겠다는 이전의 발표를 철회하는 성명을 발표하며 이 분야에서 최종 계약이 이루어지지 않았다고 밝혔습니다. 대신 회사는 슈퍼옥사이드 디스뮤타제 (SOD) 기반 보충제의 선두주자로 자리매김하여 SOD를 상업적으로 젤리 형태로 처음으로 제공합니다. 이 회사는 염증, 회복, 집중력 및 기억 지원을 위한 제품에 중점을 두고 40개 이상의 프로 및 대학 운동 팀을 포함하여 수천 명의 고객에게 서비스를 제공합니다.
Cellev8 Nutrition Inc (OTC PINK:CELV) a émis une déclaration rétractant les annonces précédentes concernant son entrée dans l'industrie du CBD/Cannabis, précisant qu'aucun accord n'a été finalisé dans ce secteur. L'entreprise s'est plutôt positionnée comme pionnière dans les suppléments à base de Dismutase Superoxyde (SOD), devenant la première à proposer SOD sous forme de gomme de manière commerciale. L'entreprise sert des milliers de clients, y compris plus de 40 équipes sportives professionnelles et universitaires, en se concentrant sur des produits pour l'inflammation, la récupération, la concentration et le soutien de la mémoire.
Cellev8 Nutrition Inc (OTC PINK:CELV) hat eine Erklärung veröffentlicht, in der frühere Ankündigungen über den Eintritt in die CBD/Cannabis-Branche zurückgenommen werden. Es wurde klargestellt, dass keine Vereinbarungen in diesem Bereich abgeschlossen wurden. Das Unternehmen hat sich stattdessen als Pionier bei Ergänzungen auf der Basis von Superoxiddismutase (SOD) positioniert und ist das erste Unternehmen, das SOD kommerziell in Gummiform anbietet. Die Firma bedient Tausende von Kunden, darunter über 40 professionelle und Hochschulsportteams, und konzentriert sich auf Produkte zur Unterstützung von Entzündungen, Erholung, Konzentration und Gedächtnis.
- First company to successfully commercialize SOD supplements in gummy form
- Established customer base including 40+ professional and collegiate athletic teams
- Retraction of previous business direction in CBD/Cannabis industry
- Failed to execute previously announced business plans from 2019-2020
WELLINGTON, FL / ACCESSWIRE / November 14, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), formerly known as Preferred Commerce, today issued a statement to clarify its business focus and retract previous announcements made on June 19, 2019, and July 1, 2020, regarding intentions to enter the CBD/Cannabis industry. The company wishes to correct the record and emphasize that while it had signed a letter of intent to explore opportunities in the CBD/Cannabis sector, it never finalized any agreements or engaged in the purchase or sale of CBD or Cannabis products. Preferred Commerce's exploration of this market did not progress beyond the initial intent phase.
Michael Ferraro, CEO of Cellev8 Nutrition Inc, stated, "Our journey led us to discover groundbreaking opportunities in the health supplement business, specifically in the realm of Superoxide Dismutase (SOD) based products. This discovery has shaped our current identity and mission." Cellev8 Nutrition Inc has established itself as a pioneer in SOD-based supplements, becoming the first company to successfully deliver SOD in gummy form on a commercial scale. The company's focus on leveraging the unmatched effects of superoxide dismutase, coupled with its patent-pending delivery mechanisms, has positioned it in a unique category within the wellness industry.
Benefits of Superoxide Dismutase Supplements Superoxide dismutase (SOD) is a powerful antioxidant enzyme that offers several potential health benefits:
1. Antioxidant Effects: SOD helps neutralize free radicals and protect cells from oxidative damage, potentially reducing inflammation and oxidative stress in the body.
2. Anti-Aging Potential: As SOD levels naturally decrease with age, supplementation may help combat age-related oxidative damage and protect skin from UV damage and signs of aging.
3. Health Support: SOD may help reduce inflammation associated with conditions like arthritis, support cardiovascular health, and have neuroprotective effects.
4. Athletic Performance: Some evidence suggests SOD supplements may aid in exercise recovery and reduce muscle damage in athletes.
5. Potential Cancer-Fighting Properties: Preliminary research indicates SOD may help inhibit tumor growth, though more studies are needed.
"We are proud to serve thousands of customers, including over 40 professional and collegiate athletic teams, who benefit from our products for inflammation, recovery, focus, and memory support," Ferraro added. "Our commitment is to expand our line of wellness products, helping people worldwide live happier and healthier lives." The company looks forward to a future dedicated to innovative wellness solutions, leaving behind any previous considerations of entering the CBD/Cannabis market.
About Cellev8 Nutrition Inc: Cellev8 Nutrition Inc, formerly Preferred Commerce, is a leading provider of Superoxide Dismutase (SOD) based supplements. The company is committed to developing cutting-edge wellness products that promote health and vitality.
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Cellev8 Nutrition Inc's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Cellev8 Nutrition Inc's filings with the Securities and Exchange Commission.
FDA Disclosure: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Contact Information
Michael Ferraro
CEO
mike@cellev8.com
561-578-0000
SOURCE: Cellev8 Nutrition Inc.
View the original press release on accesswire.com
FAQ
What is Cellev8 Nutrition's (CELV) main business focus in 2024?
Why did Cellev8 Nutrition (CELV) retract its CBD/Cannabis industry plans?
What are the key markets for Cellev8 Nutrition's (CELV) SOD supplements?
